A target-orientated algorithm for regional citrate-calcium anticoagulation in extracorporeal therapies

Blood Purification

Volumn 33, Issue 1-3, 2012, Pages 7-20

  Brandl, M ^a   Strobl, K ^a   Hartmann, J ^a   Kellner, K ^a   Posnicek, T ^a   Falkenhagen, D ^a  

^a DANUBE UNIVERSITY KREMS   (Austria)

Author keywords

Anticoagulation; Extracorporeal therapies; Regional anticoagulation; Regional citrate calcium anticoagulation

Indexed keywords

CALCIUM ION; CITRIC ACID;

ALGORITHM; ANTICOAGULATION; ARTICLE; AUTOMATION; COMPUTER PROGRAM; CONCENTRATION (PARAMETERS); DIALYSIS MEMBRANE; HEMODIALYSIS; HUMAN; LABORATORY TEST; MATHEMATICAL MODEL; MODEL; NORMAL HUMAN; PRIORITY JOURNAL; VALIDITY;

ALGORITHMS; ANTICOAGULANTS; BLOOD PROTEINS; CALCIUM; CALCIUM CHLORIDE; CITRIC ACID; EQUIPMENT DESIGN; HUMANS; MODELS, BIOLOGICAL; RENAL DIALYSIS;

EID: 80855132999     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000332394     Document Type: Article

References (31)

1. Kjellstrand CM, Gornick C, Davin T: Recovery from acute renal failure. Clin Exp Dial Apheresis 1981; 5:143-161.
2. Kaplan AA, Longnecker RE, Folkert VW: Continuous arteriovenous hemofiltration. A report of six months experience. Ann Intern Med 1984; 100: 358-367.
3. Metha RL, McDonald BR, Aguilar MM, Ward DM: Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 1991; 38: 976-981.
4. Ward DM, Metha RL: Extracorporeal management of acute renal failure patients at high risk of bleeding. K idney Int 1993; 43: 237-244.
5. Samuelsson O, Amiral J, Attman PO, Ben-negard K, Björck S, Tenborg L: Heparin-in-duced thrombocytopenia during continuous hemofiltration. Nephrol Dial Transplant 1995; 10:1768-1771.
6. Sabbatani L: Calcium et citrate trisodique dans la coagulation du sang, de la lymphe et du lait. Arch Ital Biol 1901; 36: 397.
7. Janssen M, Huijgens PC, Bouman A, Oe P, Van der Meulen J: Citrate anticoagulation and divalent cations in hemodialysis. Blood Purif 1994; 12:308-316.
8. Hartmann J, Strobl K, Fichtinger U, Falken-hagen D: Optimization of citrate anticoagu-lation. Int J Artif Organs 2007; 30:742.
9. Hartmann J, Strobl K, Fichtinger U, Falken-hagen D: Citrate anticoagulation and activation of the complement system. Int J Artif Organs 2007; 29: 538.
10. 2+ concentration on the suppression of the complement system by citrate. Int J Artif Organs 2009; 32:438.
11. Kutsogiannis D, Gibney N, Stollery D, Gao J: Regional citrate versus systemic heparin an-ticoagulation for continuous renal replacement in critically ill patients. Kidney Int 2005; 67:2361-2367.
12. Swartz R, Pasko D, Toole J, Starmann B: Improving the delivery of continuous renal replacement therapy using regional citrate an-ticoagulation. Clin Nephrol 2004; 61: 134-143.
13. Kreuzer M, Ahlenstiel T, Kanzelmeyer N, Ehrich JH, Pape L: Management of regional citrate anticoagulation in pediatric high-flux dialysis: activated coagulation time versus post-filter ionized calcium. Pediatr Nephrol 2010; 25: 1305-1310.
14. Falkenhagen D, Thijssen S, Brandl M, Hart-mann J, Strobl K: Relationship between ionized calcium concentration and activated clotting time in citrate anticoagulated blood. J Am Soc Nephrol 2010, vol 21.
15. Palsson R, Niles J: Regional citrate anticoag-ulation in continuous venovenous hemofil-tration in critically ill patients with a high risk of bleeding. Kidney Int 1999; 55: 1991-1997.
16. Elhanan N, Skippen P, Nuthall G, Krahn G, Seear M: Citrate anticoagulation in pediatric continuous venovenous hemofiltration. Pe-driatr Nephrol 2003; 19: 208-212.
17. Whitfield LR, Levy G: Permeability of human and rat red blood cells to citrate. Thromb Res 1981; 21:681-684.
18. Lee T: First Aid for the USMLE Step 1. New York, McGraw-Hill Medical, 2008.
19. Hartmann J, Strobl K, Fichtinger U, Schild-böck C, Brandl M, Falkenhagen D: In vitro investigations of citrate clearance with different dialysis filters. Submitted.
20. Davenport A, Towani A: Citrate anticoagu-lation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unit. Nephrol Dial Transplant 2009; 2:439-447.
21. Lew FT, Yukiyama Y, Waks HS, Osler AG: Activation of the alternative (properdin) pathway by divalent cations. J Immunol 1975; 115: 884-888.
22. Bakker AJ, Boerma EC, Keidel H, Kingma P, van der Voort PH: Detection of citrate overdose in critically ill patients on citrate-anti-coagulated venovenous haemofiltration: use of ionised and total/ionised calcium. Clin Chem Lab Med 2006; 44: 962-966.
23. Strobl K, Hartmann J, Falkenhagen D, Kell-ner K, Fichtinger U, Schildböck C, Posnicek T, Wallner M, Brandl M: A target orientated algorithm for citrate-calcium anticoagula-tion in clinical practice. Submitted.
24. Le T, Bhushan V, Tolles J: First Aid for the USMLE Step 1. New York, McGraw-Hill Professional, 2011.
25. Peters T: All About Albumin: Biochemistry, Genetics and Medical. San Diego, Academic Press, 1996, pp 77, 124.
26. Duncan PH, Wills MR, Smith BJ, Savory J: Clinical studies of protein-bound calcium in various diseases. Clin Chem 1982; 28:672-675.
27. Tobe SW, Aujla P, Walele AA, Oliver MJ, Nai-mark DMJ, Perkins NJ, Beardsall M: A novel regional citrate anticoagulation protocol for CRRT using only commercially available solutions. J Crit Care 2003; 18: 121-129.
28. Kozik-Jaromin J, Nier V, Heemann U, Krey-mann B, Böhler J: Citrate pharmacokinetics and calcium levels during high-flux dialysis with regional citrate anticoagulation. Nephrol Dial Transplant 2009; 24:2244-2251.
29. McLean FC, Hastings AB: The state of calcium in the fluids of the body. J Biol Chem 1935; 108:285.
30. Apsner R, Buchmayer H, Gruber D, Sunder-Plassmann G: Citrate for long-term hemodi-alysis: prospective study of 1,009 consecutive high-flux treatments in 59 patients. Am J Kidney Dis 2005; 45:557-564.
31. Szamosfalvi B, Frinak S, Yee J: Automated regional citrate anticoagulation: technological barriers and possible solutions. Blood Purif 2010; 29: 204-209.